Recruiting Non-Alcoholic Fatty Liver Disease Studies in New York
About Non-Alcoholic Fatty Liver Disease Clinical Trials in New York
Non-alcoholic fatty liver disease (NAFLD/MASLD) is a condition where excess fat builds up in the liver without significant alcohol consumption. It is the most common liver disease in Western countries. Management includes weight loss, exercise, and treatment of associated metabolic conditions.
There are currently 3 non-alcoholic fatty liver disease clinical trials recruiting participants in New York, NY. These studies are seeking a combined 190 participants. Research is being sponsored by Naga P. Chalasani, Weill Medical College of Cornell University, Icahn School of Medicine at Mount Sinai. Clinical trial participation is free and participants receive study-related medical care at no cost.
Non-Alcoholic Fatty Liver Disease Clinical Trials in New York — FAQ
Are there non-alcoholic fatty liver disease clinical trials in New York?
Yes, there are 3 non-alcoholic fatty liver disease clinical trials currently recruiting in New York, NY. Browse the studies on this page to find one that fits.
How do I join a clinical trial in New York?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New York research site will contact you about next steps.
Are clinical trials in New York free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New York studies also compensate for your time and travel.
What non-alcoholic fatty liver disease treatments are being tested?
The 3 active trials in New York are testing new therapies including novel drugs, biologics, and treatment approaches for non-alcoholic fatty liver disease.
Data updated October 15, 2026 from ClinicalTrials.gov